Reversal of ketosis in type 1 diabetes is not adversely affected by SGLT2 inhibitor therapy

Stephan Siebel, Alfonso Galderisi, Neha S. Patel, Lori R. Carria, William V. Tamborlane, Jennifer L. Sherr

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Reversal of ketosis in type 1 diabetes is not adversely affected by SGLT2 inhibitor therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences